デフォルト表紙
市場調査レポート
商品コード
1405744

北米のアドバンスド創傷ケア市場規模、シェア、動向分析レポート:製品別、用途別、最終用途別、セグメント予測、2024年~2030年

North America Advanced Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial), By Application (Chronic Wounds, Acute Wounds), By End-use (Hospitals, Specialty Clinics), And Segment Forecasts, 2024 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 90 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.16円
北米のアドバンスド創傷ケア市場規模、シェア、動向分析レポート:製品別、用途別、最終用途別、セグメント予測、2024年~2030年
出版日: 2023年12月01日
発行: Grand View Research
ページ情報: 英文 90 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

北米のアドバンスド創傷ケア市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、北米のアドバンスド創傷ケア市場規模は2024年から2030年にかけてCAGR 4.79%を記録し、2030年には67億米ドルに達すると予測されています。

高齢化社会の進展や糖尿病患者の増加が、同市場の成長を促す主な要因となっています。例えば、United Health Foundationの報告書(2023年5月発行)によると、米国には65歳以上の成人が5,580万人以上居住しており、2021年には米国人口の約16.8%を占めています。

外科手術の件数や外傷事故が増加しています。例えば、2023年8月に発行されたiData Research社のレポートによると、米国では年間90万件以上の心臓外科手術が行われており、2029年には130万件に達すると予測されています。同様に、手術部位感染症も増加しています。アドバンスド創傷ケア製品は、こうした手術部位感染を減らすのに役立ちます。手術部位感染症の増加は、予測期間中の市場成長を促進すると予想されます。

また、多くの大手メーカーが新製品を投入しており、予測期間中にアドバンスド創傷ケア製品の需要増を取り込むのに役立つ可能性があります。例えば、2022年9月、PolyNovo Limited Companyは、自社製品「NovoSorb MTX」のFDA 510(k)クリアランスを取得しました。この製品は、複雑な慢性創傷の管理に使用される予定です。このように、上記の要因が市場の成長を後押ししています。

北米のアドバンスド創傷ケア市場レポート・ハイライト

  • 製品別では、慢性創傷患者の増加により、湿潤創傷ケア分野が2023年の市場を独占しました。
  • 用途別では、糖尿病性足潰瘍の増加により、急性創傷分野が予測期間中に市場を独占する可能性が高いです。
  • 最終用途別では、入院患者の手術件数が増加していることから、病院分野がアドバンスド創傷ケア市場を独占しています。一方、在宅ヘルスケア分野は予測期間中にCAGRが最も速く成長すると予測されています。
  • 米国が2023年に最も高い収益シェアを占め、市場を席巻しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 北米のアドバンスド創傷ケア市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 北米のアドバンスド創傷ケア市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響分析

第4章 北米のアドバンスド創傷ケア市場:製品の推定・動向分析

  • 定義と範囲
    • モイスト
    • 抗菌性
    • アクティブ
  • 製品市場シェア、2018年と2030年
  • セグメントダッシュボード
  • 製品別北米アドバンスド創傷ケア市場の見通し
  • 市場規模、予測および動向分析、2023年から2030年まで

第5章 北米のアドバンスド創傷ケア市場:用途の推定・動向分析

  • 定義と範囲
    • 急性創傷
    • 慢性創傷
  • 用途市場シェア、2018年および2030年
  • セグメントダッシュボード
  • 用途別の北米アドバンスド創傷ケア市場の見通し
  • 市場規模、予測および動向分析、2023年から2030年まで

第6章 北米のアドバンスド創傷ケアデバイス:最終用途の推定・動向分析

  • 定義と範囲
    • 病院
    • 専門クリニック
    • 在宅ヘルスケア
    • その他
  • 最終用途市場シェア、2018年および2030年
  • セグメントダッシュボード
  • 最終用途別の北米アドバンスド創傷ケア市場の見通し
  • 市場規模、予測および動向分析、2018年から2030年まで

第7章 北米のアドバンスド創傷ケア市場:地域の推定・動向分析

  • 地域市場シェア分析、2023年および2030年
  • 地域市場ダッシュボード
  • 地域市場のスナップショット
  • 地域市場シェアと主要企業、2023年
    • 北米
  • 市場用途、予測および動向分析、2018年から2030年:
  • 北米
    • 市場推計・予測、2018~2030年
    • 米国
    • カナダ

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • イノベーター
  • ベンダー情勢
    • 主要ディストリビューターとチャネルパートナーのリスト
    • 主要顧客
    • 主要企業シェア分析、2023年
    • Smith &Nephew PLC
    • Molnlycke Health Care AB
    • ConvaTec Group PLC
    • Baxter International
    • URGO Medical
    • Coloplast Corp.
    • Medtronic
    • 3M
    • Derma Sciences(Integra LifeSciences)
    • Medline Industries, Inc.
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America advanced wound care market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America advanced wound care market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America advanced wound care market, by application, 2018 - 2030 (USD Million)
  • Table 6 North America advanced wound care market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 US advanced wound care market, by product, 2018 - 2030 (USD Million)
  • Table 8 US advanced wound care market, by application, 2018 - 2030 (USD Million)
  • Table 9 US advanced wound care market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada advanced wound care market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada advanced wound care market, by application, 2018 - 2030 (USD Million)
  • Table 12 Canada advanced wound care market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 North America advanced wound care market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2023)
  • Fig. 10 Segment outlook
  • Fig. 11 Strategy framework
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Consumer behavior analysis
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Market restraint relevance analysis (Current & future impact)
  • Fig. 16 Porter's five forces analysis
  • Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 18 North America advanced wound care market: Product movement analysis
  • Fig. 19 Segment dashboard
  • Fig. 20 North America advanced wound care market product outlook: Key takeaways
  • Fig. 21 Moist market, 2018 - 2030 (USD Million)
  • Fig. 22 Foam dressings market, 2018 - 2030 (USD Million)
  • Fig. 23 Hydrocolloid dressings market, 2018 - 2030 (USD Million)
  • Fig. 24 Film dressings market, 2018 - 2030 (USD Million)
  • Fig. 25 Alginate dressings market, 2018 - 2030 (USD Million)
  • Fig. 26 Hydrogel dressings market, 2018 - 2030 (USD Million)
  • Fig. 27 Collagen dressings market, 2018 - 2030 (USD Million)
  • Fig. 28 Other advanced dressings market, 2018 - 2030 (USD Million)
  • Fig. 29 Antimicrobial market, 2018 - 2030 (USD Million)
  • Fig. 30 Silver market, 2018 - 2030 (USD Million)
  • Fig. 31 Non-silver market, 2018 - 2030 (USD Million)
  • Fig. 32 Active market, 2018 - 2030 (USD Million)
  • Fig. 33 Biomaterials market, 2018 - 2030 (USD Million)
  • Fig. 34 Skin-substitute market, 2018 - 2030 (USD Million)
  • Fig. 35 North America advanced wound care market: Application movement analysis
  • Fig. 36 Segment dashboard
  • Fig. 37 North America Advanced wound care market Application outlook: Key takeaways
  • Fig. 38 Chronic wounds market, 2018 - 2030 (USD Million)
  • Fig. 39 Diabetic foot ulcers market, 2018 - 2030 (USD Million)
  • Fig. 40 Pressure ulcers market, 2018 - 2030 (USD Million)
  • Fig. 41 Venous leg ulcers market, 2018 - 2030 (USD Million)
  • Fig. 42 Other chronic wounds market, 2018 - 2030 (USD Million)
  • Fig. 43 Acute wounds market, 2018 - 2030 (USD Million)
  • Fig. 44 Surgical and traumatic wounds market, 2018 - 2030 (USD Million)
  • Fig. 45 Burns market, 2018 - 2030 (USD Million)
  • Fig. 46 North America Advanced wound care market: End-use movement analysis
  • Fig. 47 Segment dashboard
  • Fig. 48 North America advanced wound care market End-use outlook: Key takeaways
  • Fig. 49 Hospital market, 2018 - 2030 (USD Million)
  • Fig. 50 Specialty clinics market, 2018 - 2030 (USD Million)
  • Fig. 51 Home healthcare market, 2018 - 2030 (USD Million)
  • Fig. 52 Others market, 2018 - 2030 (USD Million)
  • Fig. 53 Regional outlook, 2023 & 2030
  • Fig. 54 Regional market dashboard
  • Fig. 55 Regional market place: Key takeaways
  • Fig. 56 North America advanced wound care market, 2018 - 2030 (USD Million)
  • Fig. 57 US advanced wound care market, 2018 - 2030 (USD Million)
  • Fig. 58 Canada advanced wound care market, 2018 - 2030 (USD Million)
  • Fig. 59 Company market share analysis, 2022
  • Fig. 60 Market differentiators
  • Fig. 61 Regional network map
目次
Product Code: GVR-4-68040-159-6

North America Advanced Wound Care Market Growth & Trends:

The North America advanced wound care market size is anticipated to reach USD 6.7 billion by 2030, registering a CAGR of 4.79% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growth in the aging population as well as increasing figure of diabetic patients are some major factors driving this market's growth. For instance, as per a United Health Foundation report (published in May 2023), more than 55.8 million adults aged 65 and older lived in the U.S., accounting for about 16.8% of the nation's population in 2021, increasing number of senior populations is anticipated to propel the market growth during the forecast period.

There has been a growth in the number of surgical procedures and traumatic incidents. For instance, per iData Research's report, published in August 2023, more than 900,000 cardiac surgery procedures are performed in the U.S. annually, which is expected to reach 1.3 million by 2029. Similarly, there has been an increase in the number of surgical site infections. Advanced wound care products help reduce these surgical site infections. An increase in the number of surgical site infections is expected to drive the market growth over the forecast period.

In addition, many leading manufacturers are introducing new products, which may help them capitalize on the increasing demand for advanced wound care products during the forecast period. For instance, in September 2022, PolyNovo Limited Company received FDA 510 (k) clearance for its product 'NovoSorb MTX'. This product is intended to be used to manage complex chronic wounds. Thus, the above-mentioned factors are boosting market growth.

North America Advanced Wound Care Market Report Highlights:

  • Based on product, the moist wound care segment dominated the market in 2023, owing to an increase in number of chronic wound patients
  • Based on application, the acute wound segment is likely to dominate the market in the forecast period, owing to an increase in number of diabetic foot ulcers
  • Based on the end-use, the hospital segment dominated the advanced wound care market, owing to an increasing number of surgeries among hospital patients. On the other hand, the home healthcare segment is anticipated to witness the fastest growth of CAGR over the forecast period
  • U.S. dominated the market with the highest revenue share in 2023, owing to the increasing number of surgical procedures and technological advancements

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. End-use
    • 1.1.4. Regional
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Mode of purchase outlook
    • 2.2.5. Distribution channel outlook
  • 2.3. Competitive Insights

Chapter 3. North America Advanced Wound Care Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
      • 3.2.1.2. Introduction of innovative and advanced wound products
      • 3.2.1.3. Rising geriatric population
      • 3.2.1.4. Increasing number of road accidents, trauma cases, and burns
      • 3.2.1.5. Increasing number of surgeries
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Delayed Diagnosis and lower treatment rates in emerging nations
      • 3.2.2.2. Stringent regulations for manufacturing of wound care products
  • 3.3. North America Advanced Wound Care Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Covid-19 Impact Analysis

Chapter 4. North America Advanced Wound Care Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Moist
    • 4.1.2. Antimicrobial
    • 4.1.3. Active
  • 4.2. Product Market Share, 2018 & 2030
  • 4.3. Segment Dashboard
  • 4.4. North America Advanced Wound Care Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
    • 4.5.1. Moist wound care
      • 4.5.1.1. Moist market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.2. Foam dressings
      • 4.5.1.2.1. Foam dressings market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.3. Hydrocolloid dressings
      • 4.5.1.3.1. Hydrocolloid dressings market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.4. Film dressings
      • 4.5.1.4.1. Film dressings market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.5. Alginate dressings
      • 4.5.1.5.1. Alginate dressings market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.6. Hydrogel dressings
      • 4.5.1.6.1. Hydrogel dressings market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.7. Collagen dressings
      • 4.5.1.7.1. Collagen dressings market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.1.8. Other advanced dressings
      • 4.5.1.8.1. Other advanced dressings market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Antimicrobial
      • 4.5.2.1. Antimicrobial market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.2.2. Silver
      • 4.5.2.2.1. Silver market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.2.3. Non-silver
      • 4.5.2.3.1. Non-silver market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Active
      • 4.5.3.1. Active market estimates and forecast 2018 to 2030s, (USD Million)
      • 4.5.3.2. Biomaterials
      • 4.5.3.2.1. Biomaterials market estimates and forecast 2018 to 2030 (USD Million)
      • 4.5.3.3. Skin-substitute
      • 4.5.3.3.1. Skin-substitute market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. North America Advanced Wound Care Market: Application Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Acute Wounds
    • 5.1.2. Chronic Wounds
  • 5.2. Application Market Share, 2018 & 2030
  • 5.3. Segment Dashboard
  • 5.4. North America Advanced Wound Care Market by Application Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
    • 5.5.1. Chronic Wounds
      • 5.5.1.1. Chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.2. Diabetic foot ulcers
      • 5.5.1.2.1. Diabetic foot ulcers market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.3. Pressure ulcers
      • 5.5.1.3.1. Pressure ulcers market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.4. Venous leg ulcers
      • 5.5.1.4.1. Venous leg ulcers market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.1.5. Others chronic wounds
      • 5.5.1.5.1. Others chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Acute Wounds
      • 5.5.2.1. Acute wounds market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.2. Surgical & traumatic wounds
      • 5.5.2.2.1. Surgical & traumatic wounds market estimates and forecast 2018 to 2030 (USD Million)
      • 5.5.2.3. Burns
      • 5.5.2.3.1. Burns market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. North America Advanced Wound Care Devices: End-Use Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Hospitals
    • 6.1.2. Specialty clinics
    • 6.1.3. Home healthcare
    • 6.1.4. Others
  • 6.2. End-use Market Share, 2018 & 2030
  • 6.3. Segment Dashboard
  • 6.4. North America Advanced Wound Care Market by End-use Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Hospitals
      • 6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Specialty clinics
      • 6.5.2.1. Specialty clinics market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Home healthcare
      • 6.5.3.1. Home healthcare market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.4. Others
      • 6.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. North America Advanced Wound Care Market: Regional Estimates & Trend Analysis

  • 7.1. Regional market share analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Regional Market Snapshot
  • 7.4. Regional Market Share and Leading Players, 2023
    • 7.4.1. North America
  • 7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
  • 7.6. North America
    • 7.6.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
    • 7.7.2 U.S.
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. U.S. market estimates and forecasts, 2018-2030
    • 7.7.3 Canada
      • 7.6.3.6. Key country dynamics
      • 7.6.3.7. Competitive scenario
      • 7.6.3.8. Regulatory framework
      • 7.6.3.9. Reimbursement scenario
      • 7.6.3.10. Canada market estimates and forecasts, 2018-2030

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Smith & Nephew PLC
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Molnlycke Health Care AB
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. ConvaTec Group PLC
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Baxter International
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. URGO Medical
      • 8.3.8.1. Financial performance
      • 8.3.8.2. Product benchmarking
      • 8.3.8.3. Strategic initiatives
    • 8.3.9. Coloplast Corp.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Medtronic
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. 3M
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Derma Sciences (Integra LifeSciences)
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Medline Industries, Inc.
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives